[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342270-105":59,"doc-detail-342270-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","administration-of-spermidine-and-eugenol-demonstrates-anti-tumorigenic-efficacy-on-metastatic-sw620-and-primary-caco-2-colorectal-cancer-spheroids","Administration of Spermidine and Eugenol Demonstrates Anti-Tumorigenic Efficacy on Metastatic SW620 and Primary Caco-2 Colorectal Cancer Spheroids","","The anti-cancer activity of eugenol (EUG) is established, while spermidine (SPD) remains debated and requires deeper investigation. This study evaluated wheat germ SPD (150 µM), clove EUG (100 µM), their combined regimen (SPD+EUG; 50 µM + 100 µM), and a supplemental formulation (SUPPL; 0.6 µM SPD + 50 µM EUG) on metastatic SW620 and primary Caco-2 colorectal cancer spheroids. All treatments lowered spheroid vitality and area, enlarged necrotic regions, and triggered apoptosis after 96 h, with reduced migration in 2D cultures by 48 h. Comparable effects between SPD+EUG and SUPPL indicated broad dose efficacy. In intestinal-equivalent co-culture models, SPD+EUG reduced CEA and proliferation while increasing occludin, autophagy LC3-II, and monocyte differentiation, supporting further research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/administration-of-spermidine-and-eugenol-demonstrates-anti-tumorigenic-efficacy-on-metastatic-sw620-and-primary-caco-2-colorectal-cancer-spheroids/342270/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/administration-of-spermidine-and-eugenol-demonstrates-anti-tumorigenic-efficacy-on-metastatic-sw620-and-primary-caco-2-colorectal-cancer-spheroids/342270.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatments were tested for anti-tumor effects in this study?","Question",{"text":112,"@type":113},"The study tested wheat germ spermidine (150 µM), clove eugenol (100 µM), the combined SPD+EUG treatment (50 µM + 100 µM), and a supplemental formulation (SUPPL; 0.6 µM SPD + 50 µM EUG).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did these treatments affect metastatic SW620 and Caco-2 colorectal cancer spheroids?",{"text":117,"@type":113},"Compared with untreated controls, all treatments reduced spheroid vitality and area, increased necrotic area, and induced apoptosis after 96 h, with reduced migration observed in 2D cultures after 48 h.",{"name":119,"@type":110,"acceptedAnswer":120},"What additional effects were observed in more physiologically relevant intestinal-equivalent models?",{"text":121,"@type":113},"SPD+EUG significantly reduced the spheroid CEA marker and proliferation while increasing occludin, autophagy LC3-II expression, and monocyte differentiation compared with control models.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342270,1791139943,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Article  \nAdministration of Spermidine and Eugenol Demonstrates Anti-Tumorigenic Efficacy on Metastatic SW620 and Primary Caco-2 Colorectal Cancer Spheroids  \nSilvia Dilloo 1, Anne Whittaker 1, Xinyue Chang 1, Eros D’Amen 1, Enzo Spisni 2, Silvana Hrelia 3, Cristina Angeloni 3, Marco Malaguti 3, Giovanni Dinelli 1 and Francesca Truzzi 1, *  \nCitation: Dilloo, S.; Whittaker, A.; Chang, X.; D’Amen, E.; Spisni, E.; Hrelia, S.; Angeloni, C.; Malaguti, M.; Dinelli, G.; Truzzi, F. Administration of Spermidine and Eugenol Demonstrates Anti-Tumorigenic Efficacy on Metastatic SW620 and Primary Caco-2 Colorectal Cancer Spheroids. Int. J. Mol. Sci. 2024, 25, 13362. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms252413362  \nAcademic Editor: Andrea Disanza  \nReceived: 13 October 2024  \nRevised: 6 December 2024  \nAccepted: 9 December 2024  \nPublished: 13 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Agricultural and Food Sciences, Alma Mater Studiorum—University of Bologna,  \n40127 Bologna, Italy; [silvia.dilloo2@unibo.it](silvia.dilloo2@unibo.it) (S.D.); anne.whittaker@unibo.it (A.W.);  \n[xinyue.chang2@unibo.it](xinyue.chang2@unibo.it) (X.C.); [eros.damen2@unibo.it](eros.damen2@unibo.it) (E.D.); [giovanni.dinelli@unibo.it](giovanni.dinelli@unibo.it) (G.D.)  \n2 Department of Biological, Geological, and Environmental Sciences, Alma Mater Studiorum—University of Bologna, 40127 Bologna, Italy; [enzo.spisni@unibo.it](enzo.spisni@unibo.it)  \n3 Department for Life Quality Studies, Alma Mater Studiorum—University of Bologna, 47921 Rimini, Italy; [silvana.hrelia@unibo.it](silvana.hrelia@unibo.it) (S.H.); [cristina.angeloni@unibo.it](cristina.angeloni@unibo.it) (C.A.); [marco.malaguti@unibo.it](marco.malaguti@unibo.it) (M.M.)  \n* Correspondence: [francesca.truzzi3@unibo.it](francesca.truzzi3@unibo.it); Tel.: +39-051-2096674  \nAbstract: The anti-cancer potential of eugenol (EUG) is well recognized, whereas that of spermidine (SPD) is subject to dispute and requires further research. The anti-tumorigenic potential of wheat germ SPD (150 µM) and clove EUG (100 µM), alone, in combination as SPD+EUG (50 µM + 100 µM) and, as a supplement (SUPPL; 0.6 µM SPD + 50 µM EUG), was investigated on both metastatic SW620 and primary Caco-2 colorectal cancer (CRC) spheroids. Compared to untreated controls, all treatments significantly reduced the vitality and spheroid area, increased the necrotic area, and induced apoptosis on both cell-type spheroids after 96 h, with a reduced migration evident in 2D (twodimensional) cultures after 48 h. The comparable anti-CRC effects of the SPD+EUG and the SUPPL reflected a wide-range dose efficacy of SPD and EUG. It is of note that SPD+EUG induced a synergistic effect on the increased caspase-3 expression and reduced the migration percentage in SW620 . In more physiologically relevant intestinal equivalents (healthy enterocytes [NCM460], fibroblasts [L929], and monocytes [U937]) containing embedded SW620/Caco-2 spheroids, SPD+EUG administration significantly reduced the spheroid CEA marker and proliferation, whilst simultaneously increasing occludin, autophagy LC3-II expression, and monocyte differentiation, compared to the control models. Exogenous SPD, alone and in combination with EUG, displayed an anti-CRC potential on tumor growth and metastasis, and warrants further investigation.  \nKeywords: spermidine; eugenol; SW620; Caco-2 spheroids; co-culture intestinal equivalents; anti-tumorigenic efficacy; apoptosis; migration  \n1. Introduction  \nGlobally, CRC is the third most common cancer, and the second leading cause of tumor-related deaths, with a p","cbCaiuqjFlE9YGV8","https://ap.wps.com/l/cbCaiuqjFlE9YGV8","pdf",3810013,"English","# Abstract\n# Keywords\n# 1. Introduction\n## CRC epidemiology and molecular progression","[{\"question\":\"What treatments were tested for anti-tumor effects in this study?\",\"answer\":\"The study tested wheat germ spermidine (150 µM), clove eugenol (100 µM), the combined SPD+EUG treatment (50 µM + 100 µM), and a supplemental formulation (SUPPL; 0.6 µM SPD + 50 µM EUG).\"},{\"question\":\"How did these treatments affect metastatic SW620 and Caco-2 colorectal cancer spheroids?\",\"answer\":\"Compared with untreated controls, all treatments reduced spheroid vitality and area, increased necrotic area, and induced apoptosis after 96 h, with reduced migration observed in 2D cultures after 48 h.\"},{\"question\":\"What additional effects were observed in more physiologically relevant intestinal-equivalent models?\",\"answer\":\"SPD+EUG significantly reduced the spheroid CEA marker and proliferation while increasing occludin, autophagy LC3-II expression, and monocyte differentiation compared with control models.\"}]","Administration of Spermidine and Eugenol Demonstrates Anti-Tumorigenic Efficacy on Metastatic SW620 and Primary Caco-2 Colorectal Cancer Spheroids | PDF",1790045982,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8dd131cb3ac2816efd9ed5662d16a497.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/66ba22d645249ab602276d5f16e92e8b.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afbaa1d2161cd3fe728001978fac138f.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e29502f7e97931886887f1255dbae2f.webp",980,1385]